{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["myeloid differentiation factor 88", "myocardial infarction", "nuclear factor-kappaB", "tanshinone IIA", "toll-like receptor 4", "ventricular remodelling"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29524303", "DateCompleted": {"Year": "2019", "Month": "11", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "03", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1111/jcmm.13557"], "Journal": {"ISSN": "1582-4934", "JournalIssue": {"Volume": "22", "Issue": "6", "PubDate": {"Year": "2018", "Month": "Jun"}}, "Title": "Journal of cellular and molecular medicine", "ISOAbbreviation": "J Cell Mol Med"}, "ArticleTitle": "Tanshinone IIA prevents left ventricular remodelling via the TLR4/MyD88/NF-\u03baB signalling pathway in rats with myocardial infarction.", "Pagination": {"StartPage": "3058", "EndPage": "3072", "MedlinePgn": "3058-3072"}, "Abstract": {"AbstractText": ["In this study, we aim to investigate the role of tanshinone IIA in myocardial infarction (MI), especially in left ventricular remodelling (VR) and the underlying mechanism involving the TLR4/MyD88/NF-\u03baB signalling pathway. Sprague-Dawley (SD) rats (n = 96) were selected, and 12 of them underwent sham surgery. The remaining 84 rats were subjected to MI modelling. HE and MT staining were carried out to estimate infract size, histopathological changes and fibrosis degree. Macrophage infiltration and cardiomyocyte apoptosis were evaluated by immunohistochemistry and TUNEL staining. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western blotting were used to determine the expression levels of TLR4, MyD88 and NF-\u03baB. Serum levels of IL-2, IL-6, IL-8, TNF-a, procollagen I Cpropeptide (PICP), and procollagen III N-propeptide (PIIINP) were measured using enzyme-linked immunosorbent assay (ELISA). The heart weight/body weight, mean arterial pressure (MAP), left ventricular end-systolic pressure (LVESP), +dP/dt and -dP/dt increased while the ventricular function and the left ventricular end-diastole pressure (LVEDP) decreased in MI rats. Compared with the rats undergoing sham surgery, MI rats showed larger infarct size, severer fibrosis, higher expression levels of TLR4, NF-\u03baB-P65, MyD88, IL-2, IL-6, IL-8, TNF-a, PICP and PIIINP as well as enhanced macrophage infiltration, cardiomyocyte apoptosis. After treatment with tanshinone IIA combined with LPS for 4 weeks, the rats showed better condition than those treated with only LPS. These results indicate that tanshinone IIA attenuates MI and prevents left VR. Importantly, inhibition of TLR4/MyD88/NF-\u03baB signalling pathway is a key step in this process."], "CopyrightInformation": "\u00a9 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province, China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province, China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Wang", "ForeName": "Yong-Jian", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province, China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Han", "ForeName": "Xin-Rui", "Initials": "XR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province, China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Wen", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiovasculare, The Third Hospital of Hebei Medical University, Hebei, China."}], "LastName": "Li", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiovasculare, The Third Hospital of Hebei Medical University, Hebei, China."}], "LastName": "Xu", "ForeName": "Lan", "Initials": "L"}, {"Identifier": ["0000-0002-4894-0398"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province, China."}], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province, China."}], "LastName": "Zheng", "ForeName": "Yuan-Lin", "Initials": "YL"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Cell Mol Med", "NlmUniqueID": "101083777", "ISSNLinking": "1582-1838"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Abietanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Myd88 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Myeloid Differentiation Factor 88"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Rela protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Tlr4 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor RelA"}, {"RegistryNumber": "03UUH3J385", "NameOfSubstance": "tanshinone"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage"], "DescriptorName": "Abietanes"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Macrophages"}, {"QualifierName": ["genetics"], "DescriptorName": "Myeloid Differentiation Factor 88"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Myocardial Infarction"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Myocytes, Cardiac"}, {"QualifierName": ["genetics"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["genetics"], "DescriptorName": "Toll-Like Receptor 4"}, {"QualifierName": ["genetics"], "DescriptorName": "Transcription Factor RelA"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Ventricular Remodeling"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics\u20132006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85\u2010e151.", "ArticleIdList": ["16407573"]}, {"Citation": "Jneid H, Alam M, Virani SS, Bozkurt B. Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction? Methodist Debakey Cardiovasc J. 2013;9:169\u2010172.", "ArticleIdList": ["PMC3782325", "24066201"]}, {"Citation": "Frank A, Bonney M, Bonney S, et al. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth. 2012;16:123\u2010132.", "ArticleIdList": ["PMC3457795", "22368166"]}, {"Citation": "Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post\u2010infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011;16:13\u201021.", "ArticleIdList": ["20623185"]}, {"Citation": "Mao S, Li X, Wang L, et al. Rationale and design of sodium tanshinone IIA sulfonate in left ventricular remodeling secondary to acute myocardial infarction (STAMP\u2010REMODELING) trial: a randomized controlled study. Cardiovasc Drugs Ther. 2015;29:535\u2010542.", "ArticleIdList": ["26482376"]}, {"Citation": "Anzai T. Post\u2010infarction inflammation and left ventricular remodeling: a double\u2010edged sword. Circ J. 2013;77:580\u2010587.", "ArticleIdList": ["23358460"]}, {"Citation": "Maekawa Y, Anzai T, Yoshikawa T, et al. Effect of granulocyte\u2010macrophage colony\u2010stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2004;44:1510\u20101520.", "ArticleIdList": ["15464336"]}, {"Citation": "Gao S, Liu Z, Li H, et al. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis. 2012;220:3\u201010.", "ArticleIdList": ["21774934"]}, {"Citation": "Pang H, Han B, Yu T, Peng Z. The complex regulation of tanshinone IIA in rats with hypertension\u2010induced left ventricular hypertrophy. PLoS ONE. 2014;9:e92216.", "ArticleIdList": ["PMC3960224", "24647357"]}, {"Citation": "Jiang C, Zhu W, Shao Q, et al. Tanshinone IIA protects against folic acid\u2010induced acute kidney injury. Am J Chin Med. 2016;44:737\u2010753.", "ArticleIdList": ["27222061"]}, {"Citation": "Yan L. Effect of Tanshinone IIA on cardiac function and inflammatory cytokines in patients with acute myocardial infarction. Journal of Hainan Medical University. 2016;22(17)."}, {"Citation": "Ghosh S, Dass JF. Study of pathway cross\u2010talk interactions with NF\u2010kappaB leading to its activation via ubiquitination or phosphorylation: a brief review. Gene. 2016;584:97\u2010109.", "ArticleIdList": ["26968890"]}, {"Citation": "Xie C, Kang J, Ferguson ME, et al. Blueberries reduce pro\u2010inflammatory cytokine TNF\u2010alpha and IL\u20106 production in mouse macrophages by inhibiting NF\u2010kappaB activation and the MAPK pathway. Mol Nutr Food Res. 2011;55:1587\u20101591.", "ArticleIdList": ["21887820"]}, {"Citation": "Li X, Yang J, Yang J, et al. RP105 protects against myocardial ischemia\u2010reperfusion injury via suppressing TLR4 signaling pathways in rat model. Exp Mol Pathol. 2016;100:281\u2010286.", "ArticleIdList": ["26742900"]}, {"Citation": "Plociennikowska A, Hromada\u2010Judycka A, Borzecka K, Kwiatkowska K. Co\u2010operation of TLR4 and raft proteins in LPS\u2010induced pro\u2010inflammatory signaling. Cell Mol Life Sci. 2015;72:557\u2010581.", "ArticleIdList": ["PMC4293489", "25332099"]}, {"Citation": "von Bernuth H, Picard C, Puel A, Casanova JL. Experimental and natural infections in MyD88\u2010 and IRAK\u20104\u2010deficient mice and humans. Eur J Immunol. 2012;42:3126\u20103135.", "ArticleIdList": ["PMC3752658", "23255009"]}, {"Citation": "Xu W, Yang J, Wu LM. Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Pharmazie. 2009;64:332\u2010336.", "ArticleIdList": ["19530445"]}, {"Citation": "Maekawa Y, Anzai T, Yoshikawa T. Effect of granulocyte\u2010macrophage colony\u2010stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2004;6:1510\u20101520.", "ArticleIdList": ["15464336"]}, {"Citation": "Orlans FB. Ethical decision making about animal experiments. Ethics Behav. 1997;7:163\u2010171.", "ArticleIdList": ["11655130"]}, {"Citation": "Tuo YL, Li XM, Luo J. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR\u2010143. Eur Rev Med Pharmacol Sci. 2015;19:3403\u20103411.", "ArticleIdList": ["26439035"]}, {"Citation": "Kloner RA. Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res. 2013;113:451\u2010463.", "ArticleIdList": ["23908332"]}, {"Citation": "Sheng FQ, Xu R, Cheng LX, et al. In rats with myocardial infarction, interference by simvastatin with the TLR4 signal pathway attenuates ventricular remodelling. Acta Cardiol. 2009;64:779\u2010785.", "ArticleIdList": ["20128155"]}, {"Citation": "Liang X F ZXJ, Xie S Q. The effect and mechanism of carvedilol long\u2010time ventricular remodeling in rats with myocardial infarction. Chin Heart J. 2014;26:411\u2010415."}, {"Citation": "Yu\u2010Rong D A ZY. Effect of minocycline on cardiac function in patients with acute myocardial infarction. Mod Med Health. 2009;13:1957\u20101958."}, {"Citation": "Lee HW, Ahn DH, Crawley SC, et al. Phorbol 12\u2010myristate 13\u2010acetate up\u2010regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF\u2010kappa B. J Biol Chem. 2002;277:32624\u201032631.", "ArticleIdList": ["12077118"]}, {"Citation": "Gilmore TD. Introduction to NF\u2010kappaB: players, pathways, perspectives. Oncogene. 2006;25:6680\u20106684.", "ArticleIdList": ["17072321"]}, {"Citation": "Brasier AR. The NF\u2010kappaB regulatory network. Cardiovasc Toxicol. 2006;6:111\u2010130.", "ArticleIdList": ["17303919"]}, {"Citation": "Jang SI, Kim HJ, Kim YJ, et al. Tanshinone IIA inhibits LPS\u2010induced NF\u2010kappaB activation in RAW 264.7 cells: possible involvement of the NIK\u2010IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol. 2006;542:1\u20107.", "ArticleIdList": ["16797002"]}, {"Citation": "Cavaillon JM, Haeffner\u2010Cavaillon N. Signals involved in interleukin 1 synthesis and release by lipopolysaccharide\u2010stimulated monocytes/macrophages. Cytokine. 1990;2:313\u2010329.", "ArticleIdList": ["2103331"]}, {"Citation": "Zhu HT, Bian C, Yuan JC, et al. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF\u2010kappaB signaling pathway in experimental traumatic brain injury. J Neuroinflammation. 2014;11:59.", "ArticleIdList": ["PMC3986937", "24669820"]}, {"Citation": "Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving stability of lipopolysaccharide\u2010induced NF\u2010kappaB activation. Science. 2005;309:1854\u20101857.", "ArticleIdList": ["16166516"]}, {"Citation": "Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction\u2010from repair and remodeling to regeneration. Cell Tissue Res. 2016;365:563\u2010581.", "ArticleIdList": ["PMC5010608", "27324127"]}, {"Citation": "Tang H, He H, Ji H, et al. Tanshinone IIA ameliorates bleomycin\u2010induced pulmonary fibrosis and inhibits transforming growth factor\u2010beta\u2010beta\u2010dependent epithelial to mesenchymal transition. J Surg Res. 2015;197:167\u2010175.", "ArticleIdList": ["25911951"]}, {"Citation": "Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85\u201094.", "ArticleIdList": ["11257452"]}, {"Citation": "Saeki K, Endo K, Yamasaki H. Histamine release by inorganic cations from mast cell granules isolated by different procedures. Jpn J Pharmacol. 1972;22:27\u201032.", "ArticleIdList": ["4113827"]}, {"Citation": "Haimovitz\u2010Friedman A, Cordon\u2010Cardo C, Bayoumy S, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med. 1997;186:1831\u20101841.", "ArticleIdList": ["PMC2199151", "9382882"]}, {"Citation": "Yuan X, Jing S, Wu L, Chen L, Fang J. Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia\u2010reperfusion injury in rats by activating the phosphatidylinositol 3\u2010kinase pathway. Exp Ther Med. 2014;8:973\u2010977.", "ArticleIdList": ["PMC4113531", "25120632"]}, {"Citation": "Zhen H, Wang J, Xue L, Rui J, Liu X, Chen Y. LPS\u2010pretreated bone marrow stem cells as potential treatment for myocardial infraction. Front Biosci (Landmark Ed). 2012;17:1294\u20101303.", "ArticleIdList": ["22201804"]}]}], "History": [{"Year": "2017", "Month": "5", "Day": "9"}, {"Year": "2018", "Month": "1", "Day": "5"}, {"Year": "2018", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29524303", "PMC5980158", "10.1111/jcmm.13557"]}}]}